Patent 8663661 was granted and assigned to Ratiopharm on March, 2014 by the United States Patent and Trademark Office.
The present invention relates to a solid pharmaceutical dosage form comprising ticagrelor as pharmaceutically active ingredient, to certain particles of ticagrelor and to processes of preparing the same.